Diaxonhit News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

24.09.24	Eurobio Scientific: RESULTS FOR THE 1ST HALF OF 2024 (GlobeNewswire)
02.08.24	EUROBIO SCIENTIFIC COMPLETES ACQUISITION OF ENDOPREDICT® GENOMIC TEST FROM MYRIAD GENETICS (GlobeNewswire)
31.07.24	EUROBIO SCIENTIFIC: CONCLUSION OF AN AGREEMENT BETWEEN EUROBIO SCIENTIFIC AND A CONSORTIUM LED BY EUROBIO SCIENTIFIC'S TEAM OF ENTREPRENEURS AND MANAGERS, IK PARTNERS AND NEXTSTAGE AM WITH A VIEW TO F (GlobeNewswire)
31.07.24	Eurobio Scientific: FIRST HALF 2024, A SOLID START TO THE FINANCIAL YEAR IN AN UNCERTAIN ENVIRONMENT // PROPOSED TENDER OFFER (GlobeNewswire)
07.05.24	EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER ENDOPREDICT® (GlobeNewswire)
10.04.24	EUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS (GlobeNewswire)
30.01.24	Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP (GlobeNewswire)
07.11.23	Eurobio Scientific: CATHERINE COURBOILLET TO JOIN EUROBIO SCIENTIFIC BOARD AS AN INDEPENDENT MEMBER (GlobeNewswire)
30.10.23	Eurobio Scientific - MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2023 (GlobeNewswire)
17.10.23	Eurobio Scientific: GenDx reduces organ matching time to 3 hours (GlobeNewswire)
11.10.23	Eurobio Scientific : Results for the First Half of 2023 (GlobeNewswire)
24.07.23	EUROBIO : ACCELERATION OF STRATEGIC DEPLOYMENT IN THE FIRST HALF OF 2023 (GlobeNewswire)
11.07.23	Eurobio Scientific: Capital reduction through cancellation of treasury shares (GlobeNewswire)
16.06.23	Eurobio Scientific: all resolutions approved at the Annual General Meeting (GlobeNewswire)
13.06.23	Eurobio Scientific continues its international development with the acquisition of DID in Italy, Europe's third largest diagnostics market (GlobeNewswire)
23.05.23	Eurobio Scientific becomes one of the first European companies to obtain IVDR1 CE marking of PCR tests (GlobeNewswire)
05.04.23	Eurobio Scientific : 2022 ANNUAL RESULTS - Very strong performance and strengthening of the Core Business (GlobeNewswire)
14.02.23	Eurobio Scientific: Wietse Mulder, CEO of GenDx, holds a 2% stake (GlobeNewswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V